Successful production of the first GMP batch of the CDVAX vaccine – 22nd December 2015

Home » Progress » Uncategorized » Successful production of the first GMP batch of the CDVAX vaccine – 22nd December 2015

The CDVAX consortium is pleased to announce the successful completion of the first GMP batch of the CDVAX product that will be used for clinical evaluation of the consortium’s C. difficle vaccine. Dr Annie Van Broekhoven, CEO of Q-Biologicals and the consortium member responsible for production aspects, commented that “it is a great achievement for both the CDVAX consortium and Q-Biologicals to have successfully manufactured this GMP spore vaccine batch which will be used for the clinical studies”.

Leave a Comment